HomeFileCoronary disease

Coronary disease

TCT 2018 | LRP: Infrared Technology for the Detection of Vulnerable Patients and Plaques

Despite optimal medical treatment and modification of risk factors, patients may spend long periods without symptoms and...

TCT 2018 | FAST-FFR: Angiography-Derived FFR Without Hyperemic Stimulus or Invasive Guidewire Placement

All over the world, functional lesion measurement remains underutilized due to the need for a hyperemic stimulus...

TCT 2018 | ReCre8 Trial: Permanent Polymer and Zotarolimus vs. Polymer-Free Amphilimus

Polymer-free amphilimus-eluting stents are a novel technology combining sirolimus and long-chained fatty acids. This enhances the uptake...

TCT 2018 | MAIN COMPARE: Angioplasty vs. Surgery for Left Main Coronary Artery Disease at 10 Years

Several studies (some of them recent, some of them not so much so) have compared left main...

TCT 2018 | BIONYX: Durable Polymer-Coated vs. Ultrathin-Strut, Bioresorbable Polymer-Coated DES

This work, presented at TCT 2018 and published simultaneously in The Lancet, is the first randomized study comparing...

TCT 2018 | RESET: Everolimus DES vs. Sirolimus First Generation DES at Long Term

This study had published thrombosis and revascularization rates at one year after stenting, but today one year...

TCT 2018 | ULTIMATE: IVUS Guided DES Implantation for All Vessels, for All Lesions

Intravascular Ultrasound (IVUS) guided drug eluting stent (DES) implantation is associated with less adverse events compared against...

TCT 2018 | SYNTAXES: 10 Year Follow Up is ‘Trendy’

The SYNTAX trial had a 5-year follow-up, but the SYNTAXES (“ES” for extended survival) was specifically designed...